Your browser doesn't support javascript.
loading
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy.
Nosrati, Adi; Tsai, Katy K; Goldinger, Simone M; Tumeh, Paul; Grimes, Barbara; Loo, Kimberly; Algazi, Alain P; Nguyen-Kim, Thi Dan Linh; Levesque, Mitchell; Dummer, Reinhard; Hamid, Omid; Daud, Adil.
Afiliación
  • Nosrati A; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco, Mount Zion A-743, 1600 Divisadero Street, San Francisco, CA 94143, USA.
  • Tsai KK; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco, Mount Zion A-743, 1600 Divisadero Street, San Francisco, CA 94143, USA.
  • Goldinger SM; Department of Dermatology, University Hospital of Zurich (USZ), University of Zurich, Gloriastrasse 31, Zürich 8091, Switzerland.
  • Tumeh P; Division of Dermatology, Department of Medicine, University of California Los Angeles (UCLA), 200 Medical Plaza Driveway, Los Angeles, CA 90024, USA.
  • Grimes B; Department of Epidemiology & Biostatistics, University of California, San Francisco, 550 16th Street, San Francisco, CA 94158, USA.
  • Loo K; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco, Mount Zion A-743, 1600 Divisadero Street, San Francisco, CA 94143, USA.
  • Algazi AP; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco, Mount Zion A-743, 1600 Divisadero Street, San Francisco, CA 94143, USA.
  • Nguyen-Kim TDL; Department of Interventional Radiology, University of Zurich, Rämistrasse 100, Zürich, 8091, Switzerland.
  • Levesque M; Department of Dermatology, University Hospital of Zurich (USZ), University of Zurich, Gloriastrasse 31, Zürich 8091, Switzerland.
  • Dummer R; Department of Dermatology, University Hospital of Zurich (USZ), University of Zurich, Gloriastrasse 31, Zürich 8091, Switzerland.
  • Hamid O; The Angeles Clinic and Research Institute (TACRI), 11818 Wilshire Boulevard #200, Los Angeles, CA 90025, USA.
  • Daud A; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco, Mount Zion A-743, 1600 Divisadero Street, San Francisco, CA 94143, USA.
Br J Cancer ; 116(9): 1141-1147, 2017 Apr 25.
Article en En | MEDLINE | ID: mdl-28324889
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Receptor de Muerte Celular Programada 1 / Inmunoterapia / Melanoma / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Receptor de Muerte Celular Programada 1 / Inmunoterapia / Melanoma / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos